El año pasado, Haemonetics Corp generó 563.73M USD en su segmento con mejor rendimiento, Plasma products and services. United States realizó la mayor aportación, representando 1.01B USD el año pasado. Para el último trimestre, Haemonetics Corp reportó unos ingresos de 148.32M USD para el periodo finalizado el 2023-04-01, procedentes del segmento con mejor rendimiento, Plasma products and services. United States aportó los mayores ingresos, alcanzando los 257.84M USD.

Por negocio

Ingresos operativos

Proporción

Anual

Anual

Trimestral

Plasma products and services

HospitalHospital products and services

Blood Center products and services

FY2023

FY2022

FY2021

FY2020

FY2019

Plasma products and services

563.73M(48.24%)

427.61M(43.05%)

414.27M(47.59%)

537.23M(54.35%)

501.84M(51.87%)

HospitalHospital products and services

378.11M(32.35%)

329.43M(33.17%)

216.58M(24.88%)

198.42M(20.07%)

196.54M(20.31%)

Blood Center products and services

226.82M(19.41%)

236.16M(23.78%)

239.61M(27.53%)

252.83M(25.58%)

269.20M(27.82%)

Por región

Ingresos operativos

Proporción

Anual

Anual

Trimestral

United States

Europe

Asia

Japan

other

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

United States

1.01B(74.29%)

970.01M(74.10%)

842.90M(72.13%)

639.32M(64.37%)

522.61M(60.04%)

646.20M(65.37%)

606.85M(62.72%)

Europe

175.66M(12.91%)

160.14M(12.23%)

156.68M(13.41%)

163.52M(16.46%)

159.08M(18.27%)

153.35M(15.51%)

164.50M(17.00%)

Asia

92.31M(6.78%)

107.54M(8.21%)

104.14M(8.91%)

110.80M(11.16%)

105.82M(12.16%)

109.30M(11.06%)

118.70M(12.27%)

Japan

62.41M(4.59%)

58.09M(4.44%)

61.30M(5.24%)

75.56M(7.61%)

77.68M(8.92%)

72.22M(7.31%)

69.91M(7.23%)

other

19.54M(1.44%)

13.28M(1.01%)

3.65M(0.31%)

3.99M(0.40%)

5.28M(0.61%)

7.42M(0.75%)

7.62M(0.79%)